Literature DB >> 15183507

Subfield-specific increase in brain growth protein in postmortem hippocampus of Alzheimer's patients.

J L Rekart1, B Quinn, M-M Mesulam, A Routtenberg.   

Abstract

The neuropathology of Alzheimer's disease (AD) reflects a precarious balance between neurodegenerative phenomena and reactive events of neuroplasticity. This latter aspect of AD neuropathology has received less attention than it deserves and its contribution to memory loss is therefore not well understood. To monitor neuroplastic-related events we studied the distribution of the plasticity-associated, brain growth protein GAP-43 in AD subjects and age-matched controls. In tissue from AD patients, we observed a consistent elevation of GAP-43 in a subfield of the hippocampus, stratum lacunosum moleculare. This subfield contains inputs from multiple brain regions and is known to regulate declarative memory function. Levels of potentially aberrant sprouting, as marked by elevated growth protein, were positively correlated with the severity of AD suggesting that increased expression of GAP-43 leads to a miswiring of circuits critical for memory function. Our findings suggest a mechanism, aberrant neuroplasticity, that in concert with neurodegeneration may importantly contribute to the memory loss in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183507     DOI: 10.1016/j.neuroscience.2004.03.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Cholinergic dysfunctions and enhanced oxidative stress in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats.

Authors:  Reyaz W Ansari; Rajendra K Shukla; Rajesh S Yadav; Kavita Seth; Aditya B Pant; Dhirendra Singh; Ashok K Agrawal; Fakhrul Islam; Vinay K Khanna
Journal:  Neurotox Res       Date:  2012-02-11       Impact factor: 3.911

2.  Coordinated expression of HuD and GAP-43 in hippocampal dentate granule cells during developmental and adult plasticity.

Authors:  Federico Bolognani; Daniel C Tanner; Sayuri Nixon; Hirotaka J Okano; Hideyuki Okano; Nora I Perrone-Bizzozero
Journal:  Neurochem Res       Date:  2007-06-19       Impact factor: 3.996

Review 3.  Long-lasting memory from evanescent networks.

Authors:  Aryeh Routtenberg
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

Review 4.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

5.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

6.  Protein kinase C-dependent growth-associated protein 43 phosphorylation regulates gephyrin aggregation at developing GABAergic synapses.

Authors:  Chen-Yu Wang; Hui-Ching Lin; Yi-Ping Song; Yu-Ting Hsu; Shu-Yu Lin; Pei-Chien Hsu; Chun-Hua Lin; Chia-Chi Hung; Min-Ching Hsu; Yi-Min Kuo; Yih-Jing Lee; Chung Y Hsu; Yi-Hsuan Lee
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

7.  Angiotensin-(1-7) via the mas receptor alleviates the diabetes-induced decrease in GFAP and GAP-43 immunoreactivity with concomitant reduction in the COX-2 in hippocampal formation: an immunohistochemical study.

Authors:  Waleed M Renno; Anwar G Al-Banaw; Preethi George; Asmaa A Abu-Ghefreh; Saghir Akhtar; Ibrahim F Benter
Journal:  Cell Mol Neurobiol       Date:  2012-06-19       Impact factor: 5.046

Review 8.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

Review 9.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

10.  Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.

Authors:  Krystina M Neuman; Elizabeth Molina-Campos; Timothy F Musial; Andrea L Price; Kwang-Jin Oh; Malerie L Wolke; Eric W Buss; Stephen W Scheff; Elliott J Mufson; Daniel A Nicholson
Journal:  Brain Struct Funct       Date:  2014-07-17       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.